宫颈癌术后放化疗胃肠道毒性NTCP模型:PARCER试验
基于III期PARCER试验283例宫颈癌术后放化疗患者数据,开发胃肠道毒性正常组织并发症概率(NTCP)模型。肠道V30Gy和V40Gy与急性和晚期≥G2腹泻及持续性胃肠道毒性相关;IMRT降低晚期毒性风险,根治性子宫切除加双侧淋巴结清扫增加风险。模型AUC/C-index为0.588至0.761。
要点
- 肠道V30Gy和V40Gy与急性和晚期≥G2腹泻及持续性胃肠道毒性相关。
- IMRT降低晚期≥G2和持续性胃肠道毒性风险,根治性子宫切除加双侧淋巴结清扫增加风险。
- 模型区分度有限(AUC/C-index 0.588–0.761),需外部验证并统一肠道勾画方法。
核心结论
- 宫颈癌术后放疗的急性、晚期腹泻及持续性胃肠道毒性NTCP模型纳入肠道V30Gy和V40Gy。
- 3DCRT和更广泛的 surgery 增加毒性风险。
研究设计与样本
- 基于III期PARCER试验(NCT01279135)数据,纳入283例宫颈癌术后放化疗患者。
- 测试变量包括患者与治疗特征,以及小肠、大肠、总单个肠袢和腹膜腔肠袋的剂量学参数。
- 采用LASSO筛选变量后构建Logistic或Cox多变量模型,内部性能用AUC或C-index评价。
主要发现
- 中位随访43个月。
- 肠道V30Gy和V40Gy与急性和晚期≥G2腹泻及持续性胃肠道毒性相关。
- IMRT降低晚期≥G2和持续性胃肠道毒性风险,根治性子宫切除加双侧淋巴结清扫增加风险。
- AUC/C-index范围为0.588(持续性胃肠道毒性)至0.761(晚期≥G2腹泻)。
关键数值与推荐
- 毒性终点按CTCAEv3.0定义急性和晚期≥G2腹泻及胃肠道毒性,持续性胃肠道毒性用C-MOSES定义。
- 推荐关注肠道V30Gy和V40Gy作为NTCP模型中的剂量学参数。
临床怎么用
- 可利用肠道V30Gy和V40Gy评估宫颈癌术后放疗患者的胃肠道毒性个体风险。
- 优先考虑IMRT以降低晚期≥G2和持续性胃肠道毒性风险。
局限性
- 模型仅完成内部性能评价,AUC/C-index范围0.588–0.761,区分度有限。
- 需探索额外变量以提升模型性能、就肠道勾画方法达成共识并进行外部验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: Gastrointestinal (GI) side effects are common after radiotherapy for gynecological cancers. Normal tissue complication probability (NTCP) models providing individual risk estimates for GI adverse events in gynecological cancers are not yet available. The aim of this study was to develop NTCP models for GI toxicity after postoperative (chemo)radiotherapy for cervical cancer. MATERIALS AND METHODS: Data from the phase-III PARCER trial (NCT01279135) was used. Tested variables included patient- and treatment-related characteristics and dosimetric parameters of small, large, and total individual bowel loops, and bowel bag as peritoneal space. NTCP endpoints included acute and late ≥G2 diarrhea and GI toxicity (CTCAEv3.0) and late persistent GI toxicity defined with the Cumulative-Month and Severity Score (C-MOSES). Logistic or Cox regression were used for multivariable models, selecting variables with Least Absolute Shrinkage and Selection Operator. Internal model performance was evaluated with area-under-the-curve (AUC) or C-index. RESULTS: The median follow-up of the 283 included patients was 43 months. Volumes of the bowel receiving 30 Gy (V30Gy) and 40 Gy (V40Gy) were associated with acute and late ≥G2 diarrhea and persistent GI toxicity. IMRT reduced risk of late ≥G2 and persistent GI toxicity, whereas radical hysterectomy with bilateral lymphadenectomy increased it. AUC/C-indices ranged from 0.588 (persistent GI toxicity) to 0.761 (late ≥ G2 diarrhea). CONCLUSION: NTCP models for acute and late diarrhea and persistent GI toxicity after postoperative radiotherapy for cervical cancer included bowel V30Gy and V40Gy. Furthermore, 3DCRT and more extensive surgery increased risks. Further studies should explore additional variables to improve model performance, reach consensus on bowel delineation methods, and validate models externally.
引用
- Corbeau A, Spampinato S, Charnalia M, et al. Normal tissue complication probability models for gastrointestinal toxicity after adjuvant (chemo)radiotherapy for cervical cancer in the PARCER trial. Radiother Oncol. 2026. PMID: 41698508. doi:10.1016/j.radonc.2026.111444
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。